Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

Shao-Jie Wu,1,2,* Dan-Dan Ruan,1,* Qiu-Yan Wu,1,* Yi Tang,1,2 Jian-Hui Zhang,1 Sen-Lin Cai,1,2 Yan-Feng Zhou,1,2 Jie-Wei Luo,1,3 Zhu-Ting Fang1,2 1Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China; 2D...

Full description

Bibliographic Details
Main Authors: Wu SJ, Ruan DD, Wu QY, Tang Y, Zhang JH, Cai SL, Zhou YF, Luo JW, Fang ZT
Format: Article
Language:English
Published: Dove Medical Press 2023-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
unresectable hepatocellular carcinoma
transarterial chemoembolization
drug-eluting bead
lenvatinib
pd-1 inhibitor
combined therapy
Online Access:https://www.dovepress.com/safety-and-efficacy-of-drug-eluting-bead-transarterial-chemoembolizati-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/safety-and-efficacy-of-drug-eluting-bead-transarterial-chemoembolizati-peer-reviewed-fulltext-article-JHC

Similar Items